JLM-BioCity Innovations

JLM-BioCity Pharma Biotech Oncology Cancer

Kitov Pharmaceuticals Announces Receipt of FDA’s Favorable Response to NT219’s pre-IND Meeting Package

Nov 11, 2017 - NT219 works by overcoming drug resistance of pancreatic cancer to various oncology drugs.  Kitov Pharmaceuticals (NASDAQ: KTOV; ...
Read More

Granalix BioTechnologies, founded by Prof Ruth Gabizon, is marketing a Novel Food Additive Based On Pomegranate Oil For Protection From Neurodegenerative Diseases

Granalix BioTechnologies, following its commercial launch last year of GranaGard™ a food supplement based on pomegranate oil that was shown to prevent ...
Read More
JLM-BioCity Shaarei Zedek Pharma

Updated Version of Oncological Drugs Rating Tool, developed by Prof. Nathan Cherny from Shaare Zedek Medical Center

Novermber 10, 2017 The new version of an international oncological drugs rating tool, developed by Prof. Nathan Cherny from Shaare ...
Read More
JLM-BioCity Biomed

JLM based Neteera Expands Market Reach and Senior Management

Dec 12, 2017: Neteera Technologies Ltd. [http://www.neteera.com ] announced the addition of Jason Rudd and Ilya Vatsel to the company's senior ...
Read More
JLM-BioCity Biotech

Investors Initiate Tender Offer to Take BioCanCell Private Ahead of Planned Fundraising Round

JERUSALEM, Dec. 11, 2017 (GLOBE NEWSWIRE) -- BioCancell Therapeutics (TASE:BICL), http://www.biocancell.com/ a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of ...
Read More
JLM-BioCity Biotech

Gamida Cell reports positive cancer drug trial

The company is preparing for an IPO next year, after recently raising money at a $160 million company value. Dec ...
Read More
JLM-BioCity Biomed

Brainsway raises $8.5m amid record revenue growth

Dec 11, 2017 - The company awaits a response from the FDA to an application to approve its product for use ...
Read More
JLM-BioCity Biotech

Gamida Cell Presents New Data from Key Programs at 2017 ASH Annual Meeting

Nov 1, 2017 - Gamida Cell, a leading cellular and immune therapeutics company based in Jerusalem, announced that two oral presentations ...
Read More
JLM-BioCity Biotech pharma

JLM-based Izun Pharmaceuticals Announces Positive Results from Phase 2 Double Blind Oral Mucositis Trial

Oct 11, 2017 - Izun Pharmaceuticals Corporation (“Izun”, “Company”, izunpharma.com), a clinical stage company focused on developing high efficacy products ...
Read More
JLM-BioCity Biomed

Chemo Group Invests in Modiin Based OCON Medical

Oct 17, 2017 - Ocon Medical has developed the IUB, a proprietary intrauterine platform made of a super-elastic alloy. Global healthcare ...
Read More
JLM-BioCity Bio

NovellusDx Elected to Pitch at the Galien Annual Event in New York this week

Oct 23, 2017 - NovellusDx has been selected again by the Galien Foundation organizing committee to pitch and participate in The Galien ...
Read More
JLM-BioCity Bio pharma

CIITECH Sponsors Research Project on Cannabis-Based Therapy for Asthma at Hebrew U’s Center on Cannabinoid Research

Oct 24,  2017 - CIITECH, a UK-Israel cannabis biotech startup, announced today that it has selected to sponsor a research project with ...
Read More
JLM-BioCity Bio Chemicals Agriculture

STK & Liddor Paving the way for New Biological Pipeline Production in Beit Shemesh

Oct 24 - 2017 - STK (Stockton), a leading company in the development and marketing of botanical based solutions for food ...
Read More
JLM-BioCity NimD "Cell Cure Neurosciences" "HIL Applied Medicine" "Raziel Therapetics" Pepticom "Immunovative Therapies" RenalSense NIMD

Abigail Leichman, Israel21C, Reports on 10 of the Coolest Biotech Companies in Jerusalem

September 25, 2017 - Amazing new technologies for beating conditions including breast cancer, ALS and obesity are under development in Israel’s ...
Read More
JLM-BioCity Biotech "Hebrew University" VC Jerusalem

$ 25 million investment to VC fund, Integra Holdings, who is bringing the Hebrew U’s Life Science Academic Excellence to market, led by Temasek (SIngapore)

September 27th, 2017 – Integra Holdings, an investment company exclusively focused on life science innovations originating from the Hebrew University, ...
Read More
JLM-BioCity Biotech GVHD

Korea Investment Partners to finance Jlm-based Enlivex Therapeutics’s lead compound for the prevention of Graft Vs Host Disease (GVHD)

Sept 20, 2017 - Enlivex Therapeutics Ltd., a clinical stage immunotherapy company, announced today the closing of an $8 million equity financing round ...
Read More
JLM-BioCity Biotech Rosetree

Rosetrees Trust Interdisciplinary Prize awarded to Hebrew U scientists Yaakov Nahmias and Nir Friedman

Sept 18, 2017 - The Rosetrees Trust Interdisciplinary Prize for 2017 has been awarded to two scientists from the Hebrew University ...
Read More
JLM-BioCIty biomed

JLM-based BreathVision’s Breath Volume Monitoring keeps Patients Safe in the Operating Room

Going under sedation for an operation can sometimes be riskier than the surgical procedure itself. It’s not a problem with ...
Read More
JLM-BioCity Medtronic Biomed brain

Medtronic to open development centers in Jerusalem & Yokneam in cooperation with the Israel Innovation Authority

Sept 11, 2017 - Medical equipment company Medtronic will be the first company to establish development centers in Israel in ...
Read More
JLM-BioCity Iowa Governor Kim Reynolds biomed

Iowa Economic Mission Meets Jerusalem Biotech Leaders

Jerusalem, Israel - Sept. 11, 2017 - The Iowa Economic Development Authority mission, led by Iowa Governor Kim Reynolds, met ...
Read More
JLM-BioCity Biotech

JLM based Entera Bio Raising $10m at $94m Valuation

Sept 13, 2017 - Entera is developing a drug for the treatment of osteoporosis. After announcing its general plan for ...
Read More
JLM-BioCity Biotech Biomed Flu vaccine

BiondVax to Manufacture its Universal Flu Vaccine in Jerusalem!

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV, TASE: BVXV) signed a lease agreement for a commercial facility in Jerusalem to manufacture its universal flu ...
Read More
JLM-BioCity biotech AMD

CellCure Invites the Public toJoin NeuroScience’s Clinical Trial To Treat Dry Age-Related Macular Degeneration

If you are over 50, and suffer from dry AMD (dry form, age-related macular degeneration), you may be eligible to ...
Read More
JLM-BioCity Biomed

Brainsway’s Backlog Revenues Due to Future Lease Agreements Increased 27% to $19 Million

Aug 22 2017 - Jerusalem based Brainsway Ltd. (TASE:BRIN), a leader in the advanced non-invasive treatment of brain disorders, announced ...
Read More
JLM-BioCity biotech pharma

New drug-testing technology from the Hebrew University could drastically cut animal testing

Aug 22 - Prof Yakov Nahmias's human-on-a-chip platform has the unique ability to predict risk of toxicity in pharma and ...
Read More
JLM-BioCity Biotech stem cell

Gamida Cell Announces First Patient Transplanted in Phase 1/2 Study of CordIn for Severe Aplastic Anemia and Hypoplastic MDS

August 21, 2017 — The first subject has been transplanted in an investigator-initiated study of Cordin™ for patients with severe ...
Read More
JLM-BioCity biomed JCT

Automatic Accurate Method for Measuring Blood Pressure Developed by Lev Academic Center (Jerusalem College of Technology)

Aug 12, 2017 - Automatic blood pressure devices are often used to assess blood pressure levels at home and in ...
Read More
JLM-BioCity Biomed HIL Applied Medical

HIL Applied Medical names Reno, Nevada its North American headquarters after University Collaboration

Aug 4, 2017 A continuing collaboration between Jerusalem-based HIL Applied Medical and the University of Nevada, Reno has led to ...
Read More

Oramed: On To Phase III And The Tel Aviv Stock Exchange

Aug 9 2017 - Oral Insulin Can Change the Diabetes Market Fundamentally and right now the company closest to succeeding in this ...
Read More
JLM-BioCity Oramed Simon Bruce diabetes "oral treatment" pharma

ORAMED appoints Dr. Simon Bruce as Vice President of Medical Affairs

July 18 2017 - ORAMED Pharmaceuticals Inc., a developer of oral drug delivery systems, announced today the appointment of Dr. Simon Bruce MD ...
Read More
JLM-BioCIty Hadassit Biotech startup Cellcure

BioTime and CellCure open cGMP cell therapy manufacturing site in Israel

January 3, 2017 -BioTime and its majority-owned subsidiary, CellCure Neurosciences, opened a new, 800-m2 cGMP cell therapy manufacturing facility at the ...
Read More
JLM-BioCity Gamida Biotech company

Gamida Cell Announces $3.5 Million Grant from the Israeli Government

July 20 2017 - Jerusalem- based Gamida Cell, a leader in cellular and immune therapies for the treatment of cancer ...
Read More
JLM-BioCity biotech startup NovellusDX

New partnership between Christiana Care’s Gene Editing Institute and NovellusDx aims to improve personalized cancer medicine

July 20 2017 - Personalized cancer therapies are on the horizon thanks to a new genomic cancer research partnership between the Gene ...
Read More
JLM-BioCity Biomed Orthodontics Dentistry braces

The Aerodentis braces clinical trial sheds metal brackets

The Aerodentis braces has started new clinical trials at the University of Alabama at Birmingham School of Dentistry. The treatment, called ...
Read More
JLM-BioCity AeonPharmaceuticals pharna Jerusalem biotech emergency medicine

Aeon Pharmaceuticals wins 1st place in the Pitch Competition of the Bio Executive Forum

Aeon Pharmaceuticals , a Jerusalem company, is developing a detoxification antidote to treat ER (Emergency Room) patients for alcohol poisoning. Alcohol ...
Read More
JLM-BioCity Biofeed Agritech green pesticide

BioFeed launched novel solutions for pest-control during PM’s Modi and Netanyahu visit

July 6 2017 - Biofeed launched a novel solution to the Bactrocera dorsalis and Bactrocera zonata fruit flies during a visit ...
Read More
JLM-BioCity Biodevice NIMD breast cancer therapy

Congratulations to Anan Copty, Butros Hallac, and NIMD on getting awarded a CIIRDF grant

NIMD, Non Invasive Medical Devices, a Jerusalem-based medical device startup company focused on the treatment of cancer, has been awarded ...
Read More
JLM-BioCity biotech pharma Gamida orphan genetic diseases immune therapy

Gamida Cell Ltd closes today $40 million financing!

Jerusalem based Gamida Cell Ltd., a leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases, ...
Read More
JLM-BioCity-Brainsway Deep-TMS treatment

Brainsway’s deep-TMS study in Obsessive Compulsive Disorder (OCD) Patients produces positive final results

Brainsway, located in Jerusalem, is preparing a submission to the FDA to market the device for Obsessive Compulsive Disorder (OCD) . Its ...
Read More
JLM-BioCity pharma biotech startup diabetes insulin pancreas

Betalin Therapeutics is working to cure diabetes by making Micro-Pancreases

Betalin Therapeutics is developing an Engineered Micro Pancreas (EMP) to improve the quality of life for millions of people with ...
Read More
JLM-BioCity life assisted bio device 6degrees

6Degrees is looking for pilot trial candidates to try out their new device controls digital devices for people who have lost their hand dexterity

6Degrees has developed a smart band that allows people who have lost their hand dexterity full control of digital smart ...
Read More
JLM-BioCIty Pharma Entra Bio

JLM based Entera Bio files for Nasdaq IPO

Entera Bio, a portfolio company of DNA Biomedical Solutions Ltd. (TASE: DNA) located in Jerusalem, has announced the filing of ...
Read More
JLM-BioCity Oramed pharma dual list TASE

Jerusalem based Oramed to dual list on TASE

Jerusalem based Oramed Pharmaceuticals Inc. (Nasdaq:ORMP), which develops orally administered drugs as a substitute for injections, has announced that the Israel ...
Read More
JLM-BioCity FDA approves Izun Pharmaceuticals's Curasite Hydrogel for Wound Care pharma

FDA approves Curasite™ Hydrogel Wound Care Product by JLM based Izun Pharmaceuticals

The FDA has approved the Izun Pharmaceuticals’ 510(k) application for Curasite™ Wound Care Hydrogel. Curasite™ is a proprietary topical combination ...
Read More
JLM-BioCity pharma Novolaka AtoBe

JLM based Novolaka from AtoBe won first place at the Global Pitch in China

Novalaka won first place from the 120 medical start-ups that presented. NovaLaka is an innovator of slow release drug delivery ...
Read More
JLM-BioCIty Tuutnaeur Biomed sterilization hopsital

Fortissimo buys Beit Shemesh Medical Equipment Company Tuttnauer for $100m

Fortissimo Capital has signed an agreement to acquire 100% ownership of Tuttnauer medical sterilization equipment company for $100 million. Fortissim is ...
Read More
JLM-BioCity Alyn REhabilitation Innovation Center

Innovation Center for Special-Needs Kids opens at Jerusalem’s Alyn Pediatric Rehab Hospital

The Alyn Pediatric Rehab Hospital’s new facility, Innovation Center for Special-Needs Kids, will accelerate the invention of case-specific, as well ...
Read More
JLM-BioCity Herzog Hospital new building geriatrics mental health assisted living

Herzog Hospital opened the new Samson building on May 16, 2017 and moved two departments

Founded in 1894, Herzog Hospital located at in the entrance to the city of Jerusalem, aims at improving the quality of life ...
Read More
JLM-BioCity Sharei Zedek Medical Center

Shaare Zedek Medical Center is offering services to medical, bio companies and researchers

Medical device and biotechnological companies, researchers and CROs… Looking for advanced medical equipment and facilities? A professional site at which ...
Read More

Hebrew University’s New Brain Research Center

This week, the Hebrew University of Jerusalem is dedicating its new interdisciplinary center for brain sciences. The Edmond and Lily Safra ...
Read More
Show Buttons
Share On Facebook
Share On Twitter
Share On Google Plus
Share On Linkedin
Hide Buttons